BACKGROUND: Vascular occlusion after tissue transfer is a devastating complication that can lead to complete flap loss. Spatial frequency domain imaging is a new, noncontact, noninvasive, wide-field imaging technology capable of quantifying oxygenated and deoxygenated hemoglobin levels, total hemoglobin, and tissue saturation. METHODS: Pedicled fasciocutaneous flaps on Wistar rats (400 to 500 g) were created and underwent continuous imaging using spatial frequency domain imaging before and after selective vascular occlusion. Three flap groups (control, selective arterial occlusion, and selective venous occlusion) and a fourth group composed of native skin between the flaps were measured. RESULTS: There were no statistically significant differences between the control flap group and the experimental flap groups before selective vascular occlusion: oxyhemoglobin (p=0.2017), deoxyhemoglobin (p=0.3145), total hemoglobin (p=0.2718), and tissue saturation, (p=0.0777). In the selective arterial occlusion flap group, percentage change in total hemoglobin was statistically different from that of the control flap group (p=0.0218). The remaining parameters were not statistically different from those of the control flap: percentage change in oxyhemoglobin (p=0.0888), percentage change in deoxyhemoglobin (p=0.5198), and percentage change in tissue saturation (p=0.4220). The selective venous occlusion flap group demonstrated changes statistically different compared with the control flap group: percentage change in oxyhemoglobin (p=0.0029) and deoxyhemoglobin, total hemoglobin, and tissue saturation (p<0.0001). CONCLUSIONS: Spatial frequency domain imaging provides two-dimensional, spatially resolved maps of tissue oxyhemoglobin, deoxyhemoglobin, total hemoglobin, and tissue saturation. Results presented here indicate that this can be used to quantify and detect physiologic changes that occur after arterial and venous occlusion in a rodent tissue transfer flap model. This portable, noncontact, noninvasive device may have a high clinical applicability in monitoring postoperative patients.
BACKGROUND:Vascular occlusion after tissue transfer is a devastating complication that can lead to complete flap loss. Spatial frequency domain imaging is a new, noncontact, noninvasive, wide-field imaging technology capable of quantifying oxygenated and deoxygenated hemoglobin levels, total hemoglobin, and tissue saturation. METHODS: Pedicled fasciocutaneous flaps on Wistar rats (400 to 500 g) were created and underwent continuous imaging using spatial frequency domain imaging before and after selective vascular occlusion. Three flap groups (control, selective arterial occlusion, and selective venous occlusion) and a fourth group composed of native skin between the flaps were measured. RESULTS: There were no statistically significant differences between the control flap group and the experimental flap groups before selective vascular occlusion: oxyhemoglobin (p=0.2017), deoxyhemoglobin (p=0.3145), total hemoglobin (p=0.2718), and tissue saturation, (p=0.0777). In the selective arterial occlusionflap group, percentage change in total hemoglobin was statistically different from that of the control flap group (p=0.0218). The remaining parameters were not statistically different from those of the control flap: percentage change in oxyhemoglobin (p=0.0888), percentage change in deoxyhemoglobin (p=0.5198), and percentage change in tissue saturation (p=0.4220). The selective venous occlusion flap group demonstrated changes statistically different compared with the control flap group: percentage change in oxyhemoglobin (p=0.0029) and deoxyhemoglobin, total hemoglobin, and tissue saturation (p<0.0001). CONCLUSIONS: Spatial frequency domain imaging provides two-dimensional, spatially resolved maps of tissue oxyhemoglobin, deoxyhemoglobin, total hemoglobin, and tissue saturation. Results presented here indicate that this can be used to quantify and detect physiologic changes that occur after arterial and venous occlusion in a rodent tissue transfer flap model. This portable, noncontact, noninvasive device may have a high clinical applicability in monitoring postoperative patients.
Authors: A E Cerussi; A J Berger; F Bevilacqua; N Shah; D Jakubowski; J Butler; R F Holcombe; B J Tromberg Journal: Acad Radiol Date: 2001-03 Impact factor: 3.173
Authors: P N Blondeel; M Arnstein; K Verstraete; K Depuydt; K H Van Landuyt; S J Monstrey; S S Kroll Journal: Plast Reconstr Surg Date: 2000-11 Impact factor: 4.730
Authors: Vivek Panchapakesan; Patrick Addison; Eamon Beausang; Joan E Lipa; Ralph W Gilbert; Peter C Neligan Journal: J Reconstr Microsurg Date: 2003-11 Impact factor: 2.873
Authors: John Quan Nguyen; Rolf B Saager; David J Cuccia; Kristen M Kelly; James Jakowatz; David Hsiang; Anthony J Durkin Journal: J Biomed Opt Date: 2011-12 Impact factor: 3.170
Authors: Adrien Ponticorvo; Eren Taydas; Amaan Mazhar; Christopher L Ellstrom; Jonathan Rimler; Thomas Scholz; June Tong; Gregory R D Evans; David J Cuccia; Anthony J Durkin Journal: J Surg Res Date: 2015-04-04 Impact factor: 2.192
Authors: Adrien Ponticorvo; David M Burmeister; Bruce Yang; Bernard Choi; Robert J Christy; Anthony J Durkin Journal: Biomed Opt Express Date: 2014-09-08 Impact factor: 3.732
Authors: David M Burmeister; Adrien Ponticorvo; Bruce Yang; Sandra C Becerra; Bernard Choi; Anthony J Durkin; Robert J Christy Journal: Burns Date: 2015-06-30 Impact factor: 2.744
Authors: Amaan Mazhar; Seyed A Sharif; J David Cuccia; J Stuart Nelson; Kristen M Kelly; Anthony J Durkin Journal: Lasers Surg Med Date: 2012-08-21 Impact factor: 4.025